Annual

EQS-News: PWO Supervisory Board meeting to approve financial statements

Retrieved on: 
Wednesday, April 10, 2024

With the proposed increase for 2023 we are continuing this tradition.”

Key Points: 
  • With the proposed increase for 2023 we are continuing this tradition.”
    Dividend of EUR 1.75 per share (PY: EUR 1.65 per share) proposed
    Oberkirch, March 21, 2024 – The Supervisory Board of PWO AG reviewed, discussed and approved the annual financial statements and consolidated financial statements for fiscal 2023 at its meeting today.
  • The annual financial statements of PWO AG have thus been adopted.
  • Our forecast is still based on the assumption that 2024 will see no major disruption to supply chains, e.g.
  • All reports of the PWO Group are published on its website at https://www.pwo-group.com/en/investors-press/news-publications/reports/ .

EQS-News: Fiscal year 2023: FORVIA HELLA increases sales and improves profitability

Retrieved on: 
Wednesday, April 10, 2024

Accordingly, Group-wide sales in the fiscal year 2023 increased by 12.7 percent to €8.1 billion on a currency-adjusted basis compared to the previous year.

Key Points: 
  • Accordingly, Group-wide sales in the fiscal year 2023 increased by 12.7 percent to €8.1 billion on a currency-adjusted basis compared to the previous year.
  • Taking exchange rate effects into account, reported sales improved by 10.3 percent to €8.0 billion (calendar year 2022: €7.2 billion1).
  • For the fiscal year 2024 (1 January to 31 December 2024), FORVIA HELLA expects to generate currency and portfolio-adjusted Group sales of between around €8.1 and 8.6 billion.
  • The annual report for fiscal year 2023 is now available on the website of HELLA GmbH & Co. KGaA .

EQS-News: technotrans increases revenue by 10 % and confirms strategic targets for 2025

Retrieved on: 
Wednesday, April 10, 2024

A strategy review conducted in the period under review confirmed the Group's overall strategic direction.

Key Points: 
  • A strategy review conducted in the period under review confirmed the Group's overall strategic direction.
  • The strategic targets for 2025 have been confirmed.
  • The technotrans Group increased consolidated revenue by 10 % to € 262.1 million in the 2023 financial year (previous year: € 238.2 million).
  • We are starting the new financial year 2024 with a sharper strategic focus and a high level of motivation.

Biophytis announces its 2023 financial results and provides an update on its business activities

Retrieved on: 
Wednesday, April 10, 2024

2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.

Key Points: 
  • 2024: The actual start of the study will depend on the conclusion of partnership agreements and Biophytis' financial resources.
  • Promising preclinical results for BIO101 (20-hydroxyecdysone) in obesity, suggesting beneficial metabolic effects on muscle and fat mass.
  • On this basis, Biophytis plans to start a phase 1/2 clinical trial in 2024, depending on its financial resources.
  • There is therefore significant doubt about the Company's ability to continue its business activities.

EQS-News: Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity

Retrieved on: 
Wednesday, April 10, 2024

Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity

Key Points: 
  • Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity
    The issuer is solely responsible for the content of this announcement.
  • Aumann significantly increases revenue in 2023, doubles EBITDA and achieves new record figures for order intake and liquidity
    Aumann AG ("Aumann", ISIN: DE000A2DAM03), a leading manufacturer of automation solutions for electromobility, successfully continued its profitable growth trajectory in the 2023 financial year.
  • Aumann's revenue grew dynamically by 34.5% to €289.6 million, with revenue in the E-mobility segment increasing particularly strongly by 61.2% to €229.1 million.
  • Order intake exceeded the successful previous year by 14.9% and reached a new record in the company’s history at €339.4 million.

EQS-News: MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024

Retrieved on: 
Wednesday, April 10, 2024

Berlin, 26 March 2024 - MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew its revenues by 6.5% to €954.6 million in the 2023 financial year.

Key Points: 
  • Berlin, 26 March 2024 - MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew its revenues by 6.5% to €954.6 million in the 2023 financial year.
  • The Consumer Goods segment generated revenues of €98.4 million and EBITDA of €5.9 million.
  • MBB SE acquired Aumann shares for around €8 million, Friedrich Vorwerk shares for around €37 million and own shares for around €45 million.
  • Backed by a promising start to the year, MBB expects revenues to increase to €1 billion and adjusted EBITDA margin to 10% in 2024.

EQS-News: DEUTZ achieves record earnings and looks ahead to the new year with confidence

Retrieved on: 
Wednesday, April 10, 2024

Cologne, March 19, 2024 – Within a persistently challenging macroeconomic environment, DEUTZ stayed on course in the 2023 financial year and achieved record results for revenue EBIT1.

Key Points: 
  • Cologne, March 19, 2024 – Within a persistently challenging macroeconomic environment, DEUTZ stayed on course in the 2023 financial year and achieved record results for revenue EBIT1.
  • The results for the past financial year prove that this approach is working,” notes DEUTZ CEO Dr. Sebastian C. Schulte.
  • The company is continuing to advance market consolidation in the area of classic combustion engines through targeted acquisitions and partnerships.
  • The repositioning and refocusing of the Green segment which has been initiated establishes the preconditions required to meet this objective.

EQS-News: CEWE is planning further turnover and earnings growth in 2024

Retrieved on: 
Wednesday, April 10, 2024

The targets for 2023 have thus clearly been achieved: CEWE had planned Group turnover in the range of 720 to 780 million euros and EBIT of up to 82 million euros for 2023.

Key Points: 
  • The targets for 2023 have thus clearly been achieved: CEWE had planned Group turnover in the range of 720 to 780 million euros and EBIT of up to 82 million euros for 2023.
  • CEWE is also planning further growth for the 2024 financial year: Group turnover is expected to reach a value in the range of 770 to 820 million euros in 2024, while Group EBIT is expected to be in the corridor of 77 to 87 million euros.
  • Turnover in the core business segment of Photofinishing rose significantly by 42.7 million euros or +6.9% to 658.8 million euros in 2023 (photofinishing turnover in 2022: 616.1 million euros).
  • Group turnover is expected to be in the range of EUR 770 million to EUR 820 million in 2024.

INFICON: AGM approves all motions as proposed by the Board of Directors

Retrieved on: 
Wednesday, April 10, 2024

The Annual General Meeting of INFICON Holding AG (SIX Swiss Exchange: IFCN), approved all the proposals made by the Board of Directors.

Key Points: 
  • The Annual General Meeting of INFICON Holding AG (SIX Swiss Exchange: IFCN), approved all the proposals made by the Board of Directors.
  • The General Meeting resolved to distribute CHF 20.00 per registered share for the year 2023 as ordinary dividend.
  • The AGM re-elected all Members of the Board of Directors (Dr.
  • The AGM approved all proposed changes to the Articles of Association.

EQS-News: Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024

Retrieved on: 
Wednesday, April 10, 2024

Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024

Key Points: 
  • Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024
    The issuer is solely responsible for the content of this announcement.
  • Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024
    Baden-Baden, March 15, 2024: Dr Konstantin Mettenheimer, member of the GRENKE AG Supervisory Board since July 2021 and its Deputy Chair since May 2023, has decided not to stand for re-election to the Supervisory Board at the Annual General Meeting on April 30, 2024.
  • “GRENKE AG has successfully repositioned itself in the areas of governance, compliance and digitalisation over the past three years and is clearly back on track for sustainable earnings growth,” said Dr Mettenheimer, explaining his decision.
  • After overcoming the challenges of the short-seller attack and the coronavirus pandemic, GRENKE has now cleared the path for profitable growth.